» Authors » Steffen E Petersen

Steffen E Petersen

Explore the profile of Steffen E Petersen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 376
Citations 7931
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Davidson S, Andreadou I, Antoniades C, Bartunek J, Basso C, Brundel B, et al.
Cardiovasc Res . 2025 Mar; PMID: 40084813
Animal models offer invaluable insights into disease mechanisms but cannot entirely mimic the variability and heterogeneity of human populations, nor the increasing prevalence of multi-morbidity. Consequently, employing human samples-such as...
2.
Szabo L, Cooper J, Condurache D, Dostal I, Andriamiadana G, Mathur R, et al.
Heart . 2025 Mar; PMID: 40081937
Background: Cardiovascular disease (CVD) burden and risk factor management among cancer survivors, especially in socioeconomically deprived, multiethnic populations, remain understudied. This study examines CVD burden and risk factor control in...
3.
Williams M, MacArthur J, Forsyth R, Petersen S
Eur Heart J Imaging Methods Pract . 2025 Mar; 3(1):qyaf012. PMID: 40066149
Aims: Federated learning and the creation of synthetic data are emerging tools, which may enhance the use of imaging data in cardiovascular research. This study sought to understand the perspectives...
4.
Betemariam T, Aleka A, Ahmed E, Worku T, Mebrahtu Y, Androulakis E, et al.
Eur Heart J Imaging Methods Pract . 2025 Mar; 3(1):qyaf010. PMID: 40041034
Aims: Cardiovascular magnetic resonance (CMR) imaging plays a pivotal role in diagnosing and managing cardiovascular diseases. Its use has shown sustained growth over the past years. However, there is considerable...
5.
Casas G, Rodenas-Alesina E, Limeres J, Badia-Molins C, Larranaga-Moreira J, Mirelis J, et al.
Rev Esp Cardiol (Engl Ed) . 2025 Feb; PMID: 39920987
Introduction And Objectives: Defining the probability of cardiomyopathy in individuals with excessive trabeculation of the left ventricle (ETLV) is an unmet clinical need. Our aims were: a) to describe the...
6.
Rasooly D, Giambartolomei C, Peloso G, Dashti H, Ferolito B, Golden D, et al.
Nat Cardiovasc Res . 2025 Feb; PMID: 39915329
Heart failure (HF) has limited therapeutic options. In this study, we differentiated the pathophysiological underpinnings of the HF subtypes-HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction...
7.
Cameli M, Pieroni M, Pastore M, Brucato A, Castelletti S, Crotti L, et al.
Eur Heart J Cardiovasc Imaging . 2025 Feb; PMID: 39903606
Anderson-Fabry disease (AFD) is a rare genetic disease with X-linked transmission characterized by a defect in the enzyme alpha-galactosidase A (alpha-GAL), which impairs glycosphingolipid metabolism and leads to an excessive...
8.
Yaqoob K, Naderi H, Thomson R, Aksentijevic D, Jensen M, Munroe P, et al.
Heart . 2025 Jan; PMID: 39837596
Background: The impact of early-stage chronic kidney disease (CKD) on cardiovascular outcomes, particularly when albuminuria is present, remains unclear. This study examined the associations between early CKD (stages 1 and...
9.
Suinesiaputra A, Gilbert K, Mauger C, Bluemke D, Wu C, Aung N, et al.
Heart . 2025 Jan; PMID: 39819617
Background: Statistical shape atlases have been used in large-cohort studies to investigate relationships between heart shape and risk factors. The generalisability of these relationships between cohorts is unknown. The aims...
10.
Sanghvi M, Dhall E, Chahal C, OMahony C, Mohiddin S, Savvatis K, et al.
Eur Heart J Qual Care Clin Outcomes . 2025 Jan; PMID: 39749832
Aims: In light of recent advances in imaging techniques, molecular understanding and therapeutic options in hypertrophic cardiomyopathy (HCM), we performed a systematic review of current guidelines for the diagnosis and...